Related Experiment Videos
[Effect of uremic serum and its fractions on stem cells in vivo]
Insights
Serum from children with chronic renal failure inhibits red blood cell production by affecting early precursors, not pluripotent stem cells. This finding clarifies the mechanism of anemia in kidney disease.
Area of Science:
- Nephrology
- Hematology
- Molecular Biology
Context:
- Chronic renal failure (CRF) in children and adolescents often leads to anemia.
- The exact mechanisms causing anemia in end-stage renal disease are not fully understood.
- Erythropoiesis, the production of red blood cells, is frequently impaired in CRF patients.
Purpose:
- To investigate the effect of uremic serum fractions on erythropoiesis in a preclinical model.
- To determine if uremic serum components inhibit pluripotent stem cells or more differentiated erythroid precursors.
- To elucidate the specific cellular targets responsible for the erythropoiesis-inhibiting effect in CRF.
Summary:
- Serum from 18 pediatric CRF patients was fractionated using Amicon plates and Sephadex G-25.
- Uremic serum and a 50,000 molecular mass ultrafiltrate demonstrated an erythropoiesis-inhibiting effect in polycythemic mice.
- However, specific serum fractions (50,000–5,000 and 3,000–800 molecular mass) did not affect spleen colony-forming units in irradiated mice, indicating the effect is on differentiated precursors.
Impact:
- The study suggests that the inhibitory effect of uremic serum on erythropoiesis occurs at the level of undifferentiated erythroid precursors.
- This finding helps explain the pathogenesis of anemia in chronic renal failure.
- It provides a basis for further research into targeted therapies for renal anemia.
Abstract:
Serum of 18 children and adolescents with chronic renal failure at the terminal stage of the kidney disease was fractionated on plates manufactured by Amicon Company and on Sephadex G-25. Uremic serum and ultrafiltrate with a molecular mass of 50,000 produced erythropoiesis inhibiting effect in polycythemic mice. However, the uremic serum and its fractions (50000--5000 and 3000--800) did not alter the number of microscopically visible colonies in the spleen of irradiated mice and their differentiation and proliferation compared to the mice that had received donor serum. Thus the inhibitory effect of serum and its fractions of patients with chronic renal failure is possible effected at the level of undifferentiated erythroid precursors producing no effect on the pluripotent stem cell.